Family Engagement, Cross-System Linkage to Substance Use Treatment for Juvenile Probationers -- Phase 3

November 1, 2022 updated by: Katherine Elkington, New York State Psychiatric Institute
Developed from adapting and combining two evidence-based programs, Project CONNECT (a linkage-to-services program that targets barriers within the probation and substance abuse treatment systems) and TIES (a program that teaches family engagement skills to providers), Family CONNECT is a linkage-to-services program that targets both family and system-level factors to increase youth use of and retention in substance use services. Using Linkage Specialists embedded within probation departments, Family CONNECT will be implemented in two NYS probation departments. This proposed study will evaluate the impact of Family CONNECT on (1) youth referral from probation to substance abuse treatment, (2) youth and family engagement in substance abuse treatment, (3) youth enrollment/retention in substance abuse treatment, and (4) youth substance use and recidivism. Counts of youth referred, youth who start treatment, and youth retained in treatment will be obtained from the juvenile justice agency for 6-months pre-implementation of Family Connect (i.e. baseline) and during the implementation period of e-Connect; counts of youth recidivism will be obtained 6 months following the completion of Family Connect. This study will also identify family and probation organizational factors influencing Family CONNECT implementation in probation settings. 50 caregiver-youth dyads and up to 36 probation officers will be recruited as participants in the study. Caregiver-youth dyads will be evaluated at baseline, 2 and 6 months; probation officers at baseline, 6, 12, and 18 months; linkage specialists at baseline, 6, 12, and 18 months.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Youth:

Inclusion Criteria

  1. Between 10-18 years of age
  2. English speaking
  3. A caregiver who will participate in the study
  4. MAYSI-2 score of ≥ 4 on any MAYSI-2 subscale; YASI mental health and substance use screen items; or other documented evidence of mental health or substance use problem
  5. Currently on probation

Exclusion Criteria 1. Cognitively unable to complete the interview

Caregiver:

Inclusion criteria

  1. Youth's legal guardian (or permission from legal guardian)
  2. Youth who will participate
  3. English speaking

Exclusion criteria:

1. Cognitively unable to complete the interview

Probation staff:

Inclusion criteria:

1. Currently employed at probation department

Exclusion criterion:

1. None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard of Care
This arm is comprised of caregiver-youth dyads randomized to work with the youth's probation officer as usual to link youth to substance use services.
Experimental: Family CONNECT
This arm is comprised of caregiver-youth dyads randomized to work with linkage specialists to link youth to substance use services.
Behavioral: Family CONNECT
Linkage specialists, who are clinical social workers and embedded within the probation departments, will work with specifically caregiver-youth dyads in the Family CONNECT arm to link youth to substance use services.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Youth Enrolled in Substance Use Treatment
Time Frame: Two years (study implementation period)
Count of youth participants enrolled in substance use treatment based on self-report or administrative records
Two years (study implementation period)
Youth Enrolled in Any Behavioral Health Treatment
Time Frame: Two years (study implementation period)
Number of youth enrolled in any behavioral health treatment (incl. mental health and substance use) within the past 6 months
Two years (study implementation period)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Youth Referred for Substance Use Treatment
Time Frame: Two years (study implementation period)
Number of youth referred to substance use treatment
Two years (study implementation period)
Youth Referred for Any Behavioral Health Treatment
Time Frame: two years (implementation period)
Number of youth who are referred to any behavioral health treatment
two years (implementation period)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Youth Initiated Substance Use Treatment
Time Frame: Two years (study implementation period)
Number of youth who attended an additional substance use treatment appointment following intake.
Two years (study implementation period)
Youth Initiated Any Behavioral Health Treatment
Time Frame: two years (study implementation period)
Number of youth who attended an additional behavioral health treatment appointment following intake.
two years (study implementation period)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

New York State Psychiatric Institute

Collaborators

National Institute on Drug Abuse (NIDA)

Investigators

  • Principal Investigator: Katherine S Elkington, PhD, New York State Psychiatric Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 17, 2016

Primary Completion (Actual)

December 1, 2018

Study Completion (Actual)

December 1, 2018

Study Registration Dates

First Submitted

February 7, 2017

First Submitted That Met QC Criteria

February 7, 2017

First Posted (Estimate)

February 9, 2017

Study Record Updates

Last Update Posted (Actual)

November 3, 2022

Last Update Submitted That Met QC Criteria

November 1, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 7108
  • R34DA039316 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance-Related Disorders

Clinical Trials on Family CONNECT

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe